Mirtazapine Tablet, Orally Disintegrating
Product Images NDC 65862-021

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 65862-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (15 mg (30 Tablet Bottle))

Package Label-principal Display Panel (15 mg (30 Tablet Bottle))
This is a medication called "Mirtazapine Orally Disintegrating Tablets, USP" with the strength of 15 mg per tablet. The tablets are orally disintegrating, and each bottle contains 30 tablets. The medication guide is provided separately, and the pharmacist is instructed to dispense it along with the tablets. This medication is distributed by Aurobindo Pharma USA, Inc., located in East Windsor, NJ. The medication must be stored at a temperature between 20°C and 25°C, with excursions permitted between 15°C and 30°C. The revised date of the information is September 2018.*
FDA Label Image

Package Label-principal Display Panel – 15 mg Blister Carton (5 X 6 Unit-dose) (Mirtazapine Fig2)

Package Label-principal Display Panel – 15 mg Blister Carton (5 X 6 Unit-dose) (Mirtazapine Fig2)
This is a prescription-only medication called Once-A-Day Mirtazapine Orally Disintegrating Tablets, USP, containing 15 mg of mirtazapine USP per tablet. It is distributed by Aurobindo Pharma USA, Inc. and comes in a child-resistant unit dose package. The medication should be stored at 20-25°C and protected from light and moisture. The tablets contain natural and artificial flavors and other ingredients like microcrystalline cellulose and magnesium stearate. It is recommended that patients read the enclosed prescribing information and use the medication immediately after opening an individual tablet blister pack. The medication is used to treat depression in adults. Note: The text contains errors, and some letters are replaced by symbols or special characters.*
FDA Label Image

Package Label-principal Display Panel (30 mg (30 Tablet Bottle))

Package Label-principal Display Panel (30 mg (30 Tablet Bottle))
This is a medication called Mirtazapine Orally Disintegrating Tablet, USP, which contains 30mg of the active ingredient Mirtazapine USP. The medication guide is provided separately, and it should be read carefully. The tablets should be dispensed in a tight, light-resistant container as defined in the USP. The medication should be stored in controlled room temperature and should not be exposed to light and moisture. The dosage of the medication should be taken as per the enclosed prescribing information. This medication is distributed by a company named Aurobindo Pharma USA, Inc.*
FDA Label Image

Package Label-principal Display Panel – 30 mg Blister Carton (5 X 6 Unit-dose) (Mirtazapine Fig4)

Package Label-principal Display Panel – 30 mg Blister Carton (5 X 6 Unit-dose) (Mirtazapine Fig4)
Mirtazapine is an orally disintegrating tablet medication. It comes in a chil-resistant, 5 x 6 unit dose package. Each tablet contains 30mg of Mirtazapine, along with other ingredients. This medication guide should be dispensed separately by the pharmacist along with the prescription. The standard dosage of Mirtazapine should be read from the enclosed prescribing information. The medicine must be used immediately upon opening the individual tabe ister. Store the medication in a cool and dry place, away from moisture and light.*
FDA Label Image

Package Label-principal Display Panel (45 mg (30 Tablet Bottle))

Package Label-principal Display Panel (45 mg (30 Tablet Bottle))
This is a description of a medication called Mirtazapine Orally Disintegrating Tablets, with a strength of 45mg. It is distributed by Aurobindo Pharma USA, Inc. Each bottle contains 30 tablets and a medication guide is provided separately. The tablets must be used immediately after opening the container, and the container should be kept tightly closed. The usual dosage and prescribing information can be found inside the package. The medication must be stored in a controlled room temperature, away from light and moisture. The NDC code is 65862-023-30.*
FDA Label Image

Package Label-principal Display Panel – 45 mg Blister Carton (5 X 6 Unit-dose) (Mirtazapine Fig6)

Package Label-principal Display Panel – 45 mg Blister Carton (5 X 6 Unit-dose) (Mirtazapine Fig6)
Once-A-Day Mirtazapine Orally Disintegrating Tablets is a drug product used for the treatment of depression. The package comes with 5 X6 unit doses of 45mg mirtazapine USP. The medication guide is provided separately so it should be dispensed alongside the drug by the pharmacist. It contains phenylalanine 45g per talt and should be protected from light and moisture. The unit dose package is child-resistant, and it should be stored within 3120t 25 (68" to 77°). The product is distributed by Aurabindo Pharma USA, Inc., while the usual dosage should be read following the enclosed prescribing information.*
FDA Label Image

Chemical Structure (Mirtazapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.